4,0
17. Dez. 2024
Aktueller Mitarbeiter
Los Angeles, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great benefits, WFH, unlimited PTO
Kontras
Company has gone from customer focused to supporting big pharma as the main objective it seems. Sort of lost it's way a bit since going public but still doing good things overall for consumers.